120 related articles for article (PubMed ID: 11918889)
41. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
Allegra V; Martimbianco L; Vasile A
Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
[TBL] [Abstract][Full Text] [Related]
42. Parathyroidectomy leads to decreased blood lead levels in patients with refractory secondary hyperparathyroidism.
Chu P; Wu CC; Chen CC; Lu KC
Bone; 2012 May; 50(5):1032-8. PubMed ID: 22373954
[TBL] [Abstract][Full Text] [Related]
43. Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients.
Tominaga Y; Katayama A; Sato T; Matsuoka S; Goto N; Haba T; Hibi Y; Numano M; Ichimori T; Uchida K
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii65-70. PubMed ID: 12771305
[TBL] [Abstract][Full Text] [Related]
44. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.
Komaba H; Taniguchi M; Wada A; Iseki K; Tsubakihara Y; Fukagawa M
Kidney Int; 2015 Aug; 88(2):350-9. PubMed ID: 25786097
[TBL] [Abstract][Full Text] [Related]
45. Association between clinical variables and mortality after parathyroidectomy in maintenance hemodialysis patients.
Chen JB; Chou FF; Yang CH; Hua MS
Am J Surg; 2017 Jan; 213(1):140-145. PubMed ID: 27469221
[TBL] [Abstract][Full Text] [Related]
46. Quality of life after surgery in secondary hyperparathyroidism, comparing subtotal parathyroidectomy with total parathyroidectomy with immediate parathyroid autograft: Prospective randomized trial.
Filho WA; van der Plas WY; Brescia MDG; Nascimento CP; Goldenstein PT; Neto LMM; Arap SS; Custodio MR; Bueno RO; Moyses RMA; Jorgetti V; Kruijf S; Montenegro FLM
Surgery; 2018 Nov; 164(5):978-985. PubMed ID: 30082137
[TBL] [Abstract][Full Text] [Related]
47. Parathyroidectomy and blood pressure in hemodialysis patients.
Pizzarelli F; Fabrizi F; Postorino M; Curatola G; Zoccali C; Maggiore Q
Nephron; 1993; 63(4):384-9. PubMed ID: 8459871
[TBL] [Abstract][Full Text] [Related]
48. Parathyroidectomy in dialysis patients.
de Francisco AL; Fresnedo GF; Rodrigo E; Piñera C; Amado JA; Arias M
Kidney Int Suppl; 2002 May; (80):161-6. PubMed ID: 11982831
[TBL] [Abstract][Full Text] [Related]
49. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
[TBL] [Abstract][Full Text] [Related]
50. [Hyperparathyroidism in patients with chronic renal failure: subtotal parathyroidectomy or total parathyroidectomy with autotransplantation? Experience with 121 cases].
Proye C; Carnaille B; Sautier M
J Chir (Paris); 1990 Mar; 127(3):136-40. PubMed ID: 2355055
[TBL] [Abstract][Full Text] [Related]
51. Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease.
Hargrove GM; Pasieka JL; Hanley DA; Murphy MB
Am J Nephrol; 1999; 19(5):559-64. PubMed ID: 10575184
[TBL] [Abstract][Full Text] [Related]
52. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB
Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
[TBL] [Abstract][Full Text] [Related]
53. Impact of parathyroidectomy on survival among haemodialysis patients: A prospective cohort study.
Li W; Zhang M; Du S; Yu Y; Liu J; Zhang L; Yao L
Nephrology (Carlton); 2016 Feb; 21(2):133-8. PubMed ID: 26199009
[TBL] [Abstract][Full Text] [Related]
54. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index.
Lomonte C; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Basile C
J Nephrol; 2006; 19(1):70-6. PubMed ID: 16523429
[TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands.
van der Plas WY; Dulfer RR; Koh EY; Vogt L; Appelman-Dijkstra NM; Schepers A; Rotmans JI; Pol RA; van Ginhoven TM; Hoorn EJ; Nieveen van Dijkum EJM; Engelsman AF; de Borst MH; Kruijff S;
Langenbecks Arch Surg; 2018 Dec; 403(8):999-1005. PubMed ID: 30415287
[TBL] [Abstract][Full Text] [Related]
56. The Effect of Parathyroidectomy on Risk of Hip Fracture in Secondary Hyperparathyroidism.
Isaksson E; Ivarsson K; Akaberi S; Muth A; Sterner G; Karl-Göran P; Clyne N; Almquist M
World J Surg; 2017 Sep; 41(9):2304-2311. PubMed ID: 28341917
[TBL] [Abstract][Full Text] [Related]
57. Secondary hyperparathyroidism, proinflammatory cytokines and response to epoietin in anemic maintenance dialysis patients.
Schiffl H; Stratakis D; Lang SM
Nephron; 2001 Aug; 88(4):391-2. PubMed ID: 11474240
[No Abstract] [Full Text] [Related]
58. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
[TBL] [Abstract][Full Text] [Related]
59. [Indications and efficacy of parathyroidectomy in the treatment of secondary hyperparathyroidism in patients with chronic renal failure: our experience].
Cotellese R; Mariano F; Costantini R; Francomano F; Napolitano L
Chir Ital; 2004; 56(1):47-53. PubMed ID: 15038647
[TBL] [Abstract][Full Text] [Related]
60. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
